Low-Dose Interleukin-2 Therapy: Effects in Chronic Renal Allograft Dysfunction.

被引：0
|
作者：
Schachtner, T. [1 ,2 ]
Stein, M. [2 ]
Sattler, A. [2 ]
Landwehr-Kenzel, S. [2 ]
Sawitzki, B. [2 ]
Reinke, P. [1 ,2 ]
机构：
[1] Charite, D-13353 Berlin, Germany
[2] Charite, Berlin Brandenburg Ctr Regenerat Med, D-13353 Berlin, Germany
来源：
TRANSPLANTATION | 2014年 / 98卷
关键词：
D O I：
10.1097/00007890-201407151-01585
中图分类号：
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号：
100102 ;
摘要：
A268
引用
收藏
页码：475 / 476
页数：2
相关论文
共 50 条
  • [1] Low-Dose Interleukin-2 Therapy: Effects in Chronic Renal Allograft Dysfunction.
    Schachtner, T.
    Stein, M.
    Sattler, A.
    Landwehr-Kenzel, S.
    Sawitzki, B.
    Reinke, P.
    AMERICAN JOURNAL OF TRANSPLANTATION, 2014, 14 : 475 - 476
  • [2] Low-dose interleukin-2 therapy in systemic lupus erythematosus
    La Cava, Antonio
    RHEUMATOLOGY AND IMMUNOLOGY RESEARCH, 2023, 4 (03): : 150 - 156
  • [3] Effects of low-dose recombinant interleukin-2 in human malignancies
    Lissoni, P
    CANCER JOURNAL FROM SCIENTIFIC AMERICAN, 1997, 3 : S115 - S120
  • [4] Treatment Outcome of Low-dose Interleukin-2 Therapy in Patients with Metastatic Renal Cell Carcinoma
    Takezawa, Yuta
    Izumi, Kouji
    Shimura, Yusuke
    Aerken, Maolake
    Natsagdorji, Ariunbold
    Iijima, Masashi
    Shigehara, Kazuyoshi
    Nohara, Takahiro
    Narimoto, Kazutaka
    Kadono, Yoshifumi
    Kitagawa, Yasuhide
    Konaka, Hiroyuki
    Mizokami, Atsushi
    ANTICANCER RESEARCH, 2016, 36 (09) : 4961 - 4964
  • [5] LOW-DOSE REGIMEN OF INTERLEUKIN-2 FOR METASTATIC RENAL-CARCINOMA
    SLEIJFER, DT
    JANSSEN, RAJ
    WILLEMSE, PHB
    MARTENS, A
    DELEIJ, L
    DEVRIES, EGE
    MULDER, NH
    LANCET, 1990, 335 (8704): : 1522 - 1523
  • [6] Treatment of metastatic renal cell carcinoma with low-dose interleukin-2
    Takezawa, Yuta
    Izumi, Kouji
    Nohara, Takahiro
    Narimoto, Kazutaka
    Ueno, Satoru
    Kadono, Yoshihumi
    Kitagawa, Yasuhide
    Konaka, Hiroyuki
    Mizokami, Atsushi
    Namiki, Mikio
    ANNALS OF ONCOLOGY, 2015, 26 : 145 - 145
  • [7] The promise of low-dose interleukin-2 therapy for autoimmune and inflammatory diseases
    David Klatzmann
    Abul K. Abbas
    Nature Reviews Immunology, 2015, 15 : 283 - 294
  • [8] SUCCESSFUL THERAPY OF MELANOMA WITH A REGIMEN OF LOW-DOSE CYCLOPHOSPHAMIDE AND INTERLEUKIN-2
    MITCHELL, MS
    KEMPF, RA
    HAREL, W
    SHAU, H
    BOSWELL, WD
    LIND, S
    DEAN, G
    MOORE, J
    BRADLEY, EC
    MOLECULAR AND CELLULAR NETWORKS FOR CANCER THERAPY, 1989, 857 : 61 - 74
  • [9] Low-Dose Interleukin-2 as an Alternative Therapy for Refractory Lupus Nephritis
    Zhang, Xia
    Feng, Ruiling
    Shao, Miao
    Wang, Yifan
    Sun, Xiaolin
    He, Jing
    RHEUMATOLOGY AND THERAPY, 2021, 8 (04) : 1905 - 1914
  • [10] RESPONSE OF THERAPY-RELATED MYELODYSPLASIA TO LOW-DOSE INTERLEUKIN-2
    TOZE, CL
    BARNETT, MJ
    KLINGEMANN, HG
    LEUKEMIA, 1993, 7 (03) : 463 - 465
12345